Novel Use of Leflunomide and Malononitrilamides

ADVERTISEMENT RETURN TO ISSUEPREVPatent HighlightNEXTNovel Use of Leflunomide and MalononitrilamidesPatent HighlightGerard Rosse*View Author Information Structure Guided Chemistry, Dart Neuroscience LLC, 7473 Lusk Boulevard, San Diego, California 92121*Address: 7473 Lusk Boulevard, San Diego, California 92121, United States. E-mail: [email protected]Cite this: ACS Med. Chem. Lett. 2012, 3, 10, 785Publication Date (Web):August 31, 2012Publication History Published online31 August 2012Published inissue 11 October 2012https://pubs.acs.org/doi/10.1021/ml300243zhttps://doi.org/10.1021/ml300243zeditorialACS PublicationsCopyright © 2012 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views929Altmetric-Citations1LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (156 KB) Get e-AlertscloseSUBJECTS:Diseases and disorders,Immunotherapy,Peptides and proteins,Pharmaceuticals Get e-Alerts